SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Goodman M, Bostick RM, Kucuk O, Jones DP. Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med. 2011; 51: 1068-1084.
  • 2
    Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996; 88: 1550-1559.
  • 3
    Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39-51.
  • 4
    Foksinski M, Gackowski D, Rozalski R, et al. Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr. 2007; 46: 174-180.
  • 5
    Lutsenko EA, Carcamo JM, Golde DW. Vitamin C prevents DNA mutation induced by oxidative stress. J Biol Chem. 2002; 277: 16895-16899.
  • 6
    Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005; 64: 527-542.
  • 7
    Bravi F, Polesel J, Bosetti C, et al. Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann Oncol. 2011; 22: 202-206.
  • 8
    Bueno de Mesquita HB, Maisonneuve P, Runia S, Moerman CJ. Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in the Netherlands. Int J Cancer. 1991; 48: 540-549.
  • 9
    Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population based case control study in the San Francisco Bay Area. Int J Cancer. 2010; 127: 1893-1904.
  • 10
    Howe G, Ghadirian P, de Mesquita H, et al. A collaborative case control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer. 1992; 51: 365-372.
  • 11
    Ji BT, Chow WH, Gridley G, et al. Dietary factors and the risk of pancreatic cancer: a case-control study in Shanghai China. Cancer Epidemiol Biomarkers Prev. 1995; 4: 885-893.
  • 12
    Lin Y, Tamakoshi A, Hayakawa T, Naruse S, Kitagawa M, Ohno Y. Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan. J Gastroenterol. 2005; 40: 297-301.
  • 13
    Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes Control. 1991; 2: 291-297.
  • 14
    Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998; 90: 1710-1719.
  • 15
    Zatonski W, Przewozniak K, Howe G, Maisonneuve P, Walker A, Boyle P. Nutritional factors and pancreatic cancer: a case control study from South West Poland. Int J Cancer. 1991; 48: 390-394.
  • 16
    Farrow DC, Davis S. Diet and the risk of pancreatic cancer in men. Am J Epidemiol. 1990; 132: 423-431.
  • 17
    Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer. 1991; 47: 1-6.
  • 18
    Howe GR, Jain M, Miller AB. Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study. Int J Cancer. 1990; 45: 604-608.
  • 19
    Kalapothaki V, Tzonou A, Hsieh C, et al. Nutrient intake and cancer of the pancreas: a case-control study in Athens, Greece. Cancer Causes Control. 1993; 4: 383-389.
  • 20
    Heinen MM, Verhage BAJ, Goldbohm RA, van den Brandt PA. Intake of vegetables, fruits, carotenoids and vitamins C and E and pancreatic cancer risk in the Netherlands Cohort Study. Int J Cancer. 2012; 130: 147-158.
  • 21
    Shibata A, Mack TM, Paganini Hill A, Ross RK, Henderson BE. A prospective study of pancreatic cancer in the elderly. Int J Cancer. 1994; 58: 46-49.
  • 22
    Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol. 2002; 155: 783-792.
  • 23
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004; 364: 1219-1228.
  • 24
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers [serial online]. Cochrane Database Syst Rev. 2008;( 3): CD004183.
  • 25
    White E, Patterson RE, Kristal AR, et al. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol. 2004; 159: 83-93.
  • 26
    Schakel SF, Buzzard IM, Gebhardt SE. Procedures for estimating nutrient values for food composition databases. J Food Compos Anal. 1997; 10: 102-114.
  • 27
    Satia-Abouta J, Patterson RE, King IB, et al. Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol. 2003; 157: 944-954.
  • 28
    Panel on Micronutrients; Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Food and Nutrition Board; Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: Institute of Medicine, National Academy of Sciences; 2002.
  • 29
    Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: Institute of Medicine, National Academy of Sciences; 2000.
  • 30
    Russo MW, Murray SC, Wurzelmann JI, Woosley JT, Sandler RS. Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer. 1997; 28: 125-129.
  • 31
    Amaral AF, Cantor KP, Silverman DT, Malats N. Selenium and bladder cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2407-2415.
  • 32
    Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev. 2004; 13: 771-778.
  • 33
    Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006; 42: 2463-2471.
  • 34
    Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr. 2004; 91: 11-28.
  • 35
    Banim PJ, Luben R, McTaggart A, et al. Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers [published online ahead of print July 23, 2012]. Gut. 2012.
  • 36
    Burney PG, Comstock GW, Morris JS. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr. 1989; 49: 895-900.
  • 37
    Amaral AF, Porta M, Silverman DT, et al. Pancreatic cancer risk and levels of trace elements. Gut. 2012; 61: 1583-1588.
  • 38
    Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001; 4( 2B): 593-599.
  • 39
    Longtin R. Selenium for prevention: eating your way to better DNA repair? J Natl Cancer Inst. 2003; 95: 98-100.
  • 40
    Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M. Selenium for preventing cancer [serial online]. Cochrane Database Syst Rev. 2011;( 5): CD005195.
  • 41
    Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007; 147: 217-223.
  • 42
    Stranges S, Laclaustra M, Ji C, et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr. 2010; 140: 81-87.
  • 43
    Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008; 168: 404-410.
  • 44
    US Department of the Interior. National Geochemical Survey: Selenium in Counties of the Northwestern US. Washington, DC: US Department of the Interior; 2004.
  • 45
    van Loon AJ, Brug J, Goldbohm RA, van den Brandt PA, Burg J. Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med. 1995; 23: 110-120.
  • 46
    Dutta Roy S, Kupp DV, Slavin JP, Corless DJ, Deakin M. Inequity of upper gastrointestinal cancer distribution and survival with socioeconomic deprivation: a population-based study. Surgery. 2005; 138: 859-868.
  • 47
    Brown J, Harding S, Bethune A, Rosato M. Longitudinal study of socio-economic differences in the incidence of stomach, colorectal and pancreatic cancers. Popul Trends. 1998; 94: 35-41.
  • 48
    Blakely T, Shaw C, Atkinson J, Cunningham R, Sarfati D. Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004. Cancer Causes Control. 2011; 22: 1307-1318.